Ifedayo Adetifa
Prevalence, spatial and temporal distribution of tungiasis in the Kilifi Health and Demographic Surveillance System (KHDSS) in Kenya.Ouma N
Muchiri SK
Nyundo C
Walumbe D
Nyaguara A
Maia M
Adetifa I
Orindi B
Bejon P
Fillinger U
Elson L
BMJ Glob Health, (2026). 11:
Seroprevalence of antibodies against diphtheria, tetanus, and pertussis over a 12-year period in children in Kilifi, Kenya (2009-2021).Mburu CN
Ojal J
Selim R
Ombati R
Akech D
Karia B
Tuju J
Sigilai A
Smits G
van Gageldonk PGM
van der Klis FRM
Flasche S
Kagucia EW
Scott J
Adetifa I
Int J Infect Dis, (2026). 164:108396
Modelling the relative contribution of infection, routine vaccination and supplementary immunisation activities to measles seroconversion in Kenyan Children.Mburu C
Ojal J
Selim R
Ombati R
Akech D
Karia B
Tuju J
Sigilai A
Smits G
Gageldonk PV
Klis FV
Kagucia E
Scott A
Adetifa I
Flasche S
PLoS Comput Biol, (2025). 21:e1013531
Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration.Kagucia EW
Voller S
Ziraba AK
Bigogo G
Munywoki PK
Makobu K
Nokes DJ
Nyagwange J
Orlendo C
Akech D
Sigilai A
Onyango C
Juma B
Herman-Roloff A
Munyua P
Apondi C
Lidechi S
Audi A
Ouma A
Aol G
Misore T
Nasimiyu C
Onyango D
Lo T
Kasera K
Jalang'o R
Kingwara L
Adetifa I
Etyang AO
Warimwe G
Agweyu A
Scott JAG
Gates Open Res, (2025). 8:60
Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adults.Abouyannis M
Nyambura YK
Ngome S
Riako D
Musyoki J
Muiruri C
Orindi B
Else L
Amara A
Dickinson L
Clare RH
Albulescu LO
Westhorpe AP
Kool J
Adetifa I
Ndungu FM
FitzGerald R
Khoo S
Lalloo DG
Casewell NR
Hamaluba M
EBioMedicine, (2025). 113:105600
Tungiasis among children in Kenya is associated with poor nutrition status, absenteeism, poor school performance and high impact on quality of life.Elson L
Kamau C
Koech S
Muthama C
Gachomba G
Sinoti E
Chondo E
Mburu E
Wakio M
Lore J
Maia M
Adetifa I
Orindi B
Bejon P
Fillinger U
PLoS Negl Trop Dis, (2024). 18:e0011800
National prevalence and risk factors for tungiasis in Kenya.Elson L
Kamau C
Koech S
Muthama C
Gachomba G
Sinoti E
Chondo E
Mburu E
Wakio M
Lore J
Maia M
Adetifa I
Orindi B
Bejon P
Fillinger U
Infect Dis Poverty, (2023). 12:85
SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021.Etyang AO
Adetifa I
Omore R
Misore T
Ziraba AK
Ng'oda MA
Gitau E
Gitonga J
Mugo D
Kutima B
Karanja H
Toroitich M
Nyagwange J
Tuju J
Wanjiku P
Aman R
Amoth P
Mwangangi M
Kasera K
Ng'ang'a W
Akech D
Sigilai A
Karia B
Karani A
Voller S
Agoti CN
Ochola-Oyier LI
Otiende M
Bottomley C
Nyaguara A
Uyoga S
Gallagher K
Kagucia EW
Onyango D
Tsofa B
Mwangangi J
Maitha E
Barasa E
Bejon P
Warimwe GM
Scott JAG
Agweyu A
PLOS Glob Public Health, (2022). 2:e0000883
TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults).Abouyannis M
FitzGerald R
Ngama M
Mwangudzah H
Nyambura YK
Ngome S
Riako D
Babu L
Lewa F
Else L
Dily Penchala S
Orindi B
Mumba N
Kalama B
Ndungu FM
Adetifa I
Khoo S
Lalloo DG
Casewell NR
Hamaluba M
Wellcome Open Res, (2022). 7:90
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.Sparrow E
Adetifa I
Chaiyakunapruk N
Cherian T
Fell DB
Graham BS
Innis B
Kaslow DC
Karron RA
Nair H
Neuzil KM
Saha S
Smith PG
Srikantiah P
Were F
Zar HJ
Feikin D
Vaccine, (2022). 40:3506-3510
The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya.Mburu CN
Ojal J
Chebet R
Akech D
Karia B
Tuju J
Sigilai A
Abbas K
Jit M
Funk S
Smits G
van Gageldonk PGM
van der Klis FRM
Tabu C
Nokes DJ
Lshtm Cmmid Covid- Working Group
Scott J
Flasche S
Adetifa I
BMC Med, (2021). 19:35
Upper airways colonisation of Streptococcus pneumoniae in adults aged 60 years and older: A systematic review of prevalence and individual participant data meta-analysis of risk factors.Smith EL
Wheeler I
Adler H
Ferreira DM
Sa-Leao R
Abdullahi O
Adetifa I
Becker-Dreps S
Esposito S
Farida H
Kandasamy R
Mackenzie GA
Nuorti JP
Nzenze S
Madhi SA
Ortega O
Roca A
Safari D
Schaumburg F
Usuf E
Sanders EAM
Grant LR
Hammitt LL
O'Brien KL
Gounder P
Bruden DJT
Stanton MC
Rylance J
J Infect, (2020). 81:540-548
Impact of the Introduction of Rotavirus Vaccine on Hospital Admissions for Diarrhea Among Children in Kenya: A Controlled Interrupted Time-Series Analysis.Otieno GP
Bottomley C
Khagayi S
Adetifa I
Ngama M
Omore R
Ogwel B
Owor BE
Bigogo G
Ochieng JB
Onyango C
Juma J
Mwenda J
Tabu C
Tate JE
Addo Y
Britton T
Parashar UD
Breiman RF
Verani JR
Nokes DJ
Clin Infect Dis, (2020). 70:2306-2313
Observational study: 27 years of severe malaria surveillance in Kilifi, Kenya.Njuguna P
Maitland K
Nyaguara A
Mwanga D
Mogeni P
Mturi N
Mohammed S
Mwambingu G
Ngetsa C
Awuondo K
Lowe B
Adetifa I
Scott JAG
Williams TN
Atkinson S
Osier F
Snow RW
Marsh K
Tsofa B
Peshu N
Hamaluba M
Berkley JA
Newton CRJ
Fondo J
Omar A
Bejon P
BMC Med, (2019). 17:124
Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya.Ojal J
Griffiths U
Hammitt LL
Adetifa I
Akech D
Tabu C
Scott JAG
Flasche S
Lancet Glob Health, (2019). 7:e644-e654
Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis.Silaba M
Ooko M
Bottomley C
Sande J
Benamore R
Park K
Ignas J
Maitland K
Mturi N
Makumi A
Otiende M
Kagwanja S
Safari S
Ochola V
Bwanaali T
Bauni E
Gleeson F
Deloria Knoll M
Adetifa I
Marsh K
Williams TN
Kamau T
Sharif S
Levine OS
Hammitt LL
Scott JAG
Lancet Glob Health, (2019). 7:e337-e346
Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data.Ojal J
Flasche S
Hammitt LL
Akech D
Kiti MC
Kamau T
Adetifa I
Nurhonen M
Scott JAG
Auranen K
Vaccine, (2017). 35:4561-4568
